Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature

BACKGROUND: Primary central nervous system lymphoma(PCNSL) is a rare kind of non-Hodgkin lymphoma. Rituximab combined with high-dose methotrexate, cytarabine and dexamethasone (R-MAD regimen) were reported effective for PCNSL patients. Rituximab can cause several side effects, including fever, chill...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuchen, Sun, Xuefei, Liu, Jing, Qian, Jun, Bai, Xueyan, Chen, Yuedan, Liu, Yuanbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393842/
https://www.ncbi.nlm.nih.gov/pubmed/32922862
http://dx.doi.org/10.1186/s41016-017-0106-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393842/
https://www.ncbi.nlm.nih.gov/pubmed/32922862
http://dx.doi.org/10.1186/s41016-017-0106-3

Ejemplares similares